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Segregation of hematuria in thin basement membrane disease after infections, hypertension, and stones [1–3]. Individu-
with haplotypes at the loci for Alport syndrome. als with TBMD have persistent microscopic glomerular
Background. Inherited hematuria is common and is usually hematuria, sometimes with proteinuria or hypertension,attributed to thin basement membrane disease (TBMD). The
but renal function is usually normal [1–5]. The diagnosisaim of this study was to determine how often hematuria in
families with TBMD segregated with haplotypes at the chromo- is made when there is a thinned glomerular basement
somal loci for autosomal recessive and X-linked Alport syn- membrane (GBM) on ultrastructural examination of the
drome (COL4A3/COL4A4 and COL4A5, respectively). renal biopsy. TBMD is often inherited, when it thenMethods. The families of 22 individuals with TBMD on renal
demonstrates autosomal dominant transmission and af-biopsy and with urinary glomerular red blood cell (RBC)
counts of more than 50,000/mL were studied using phase-con- fects approximately half of successive generations [2–4].
trast microscopy of the urine and DNA microsatellite markers. It has recently been suggested that TBMD represents
Eighteen families had at least two members with hematuria. a carrier state for autosomal recessive or X-linked AlportResults. Hematuria segregated with or was consistent with
syndrome [6]. The evidence for this is that heterozygoussegregation at the COL4A3/COL4A4 locus in eight (36%)
families (P , 0.05 in 5 of these) and at the COL4A5 locus in carriers of the causative mutations in autosomal recessive
four (18%) families (P , 0.05 in 2). The lack of segregation Alport syndrome [7, 8] and female carriers of X-linked
in the other 10 (45%) families may have occurred because of Alport syndrome [9] can have a thinned GBM that isincomplete penetrance of the hematuria, de novo mutations,
identical to that seen in TBMD.coincidental hematuria in other family members, or the pres-
ence of a novel gene locus. In four different families, three The aim of this study was to determine how often
of which had hematuria that segregated with the COL4A3/ hematuria in families with TBMD segregated with the
COL4A4 locus, four family members with the hematuria haplo- genetic loci for autosomal recessive and X-linked Alporttype had spouses with coincidental hematuria (4 of 29, 14%).
syndrome. Type IV collagen is the predominant proteinHowever, none of their four offspring who had also inherited
the hematuria haplotype had the clinical features of autosomal found in the GBM, and autosomal recessive and X-linked
recessive Alport syndrome. Alport syndrome affect the genes encoding the a3(IV),
Conclusions. Hematuria in families with TBMD commonly
a4(IV) (COL4A3/COL4A4), and a5(IV) (COL4A5) col-segregates with the COL4A3/COL4A4 locus and thus results
lagen chains, respectively [10, 11].from mutations in the same genes as autosomal recessive Al-
port syndrome. Sometimes TBMD may be confused with the
carrier state for X-linked Alport syndrome. However, nearly
METHODShalf of the families in this study had hematuria that did not seg-
regate with the loci for either autosomal recessive or X-linked Index cases were consecutive patients with TBMD re-Alport syndrome.
ferred because of a family history of hematuria (N 5 10)
or, subsequently, consecutive patients diagnosed with
TBMD at our medical center (N 5 12). Only one familyThin basement membrane disease (TBMD) or “benign
that was invited refused to take part in the study.familial hematuria” probably affects at least 1% of the
All index cases had TBMD on renal biopsy and morecommunity and is thus the most common renal condition
than 50,000 glomerular or dysmorphic red blood cells
(RBCs)/mL on phase-contrast microscopy [12] of a mid-Key words: hematuria, inherited disease, gene mutation, benign famil-
ial hematuria, collagen chains. stream urine specimen on two or more occasions. These
urines contained at least three different populations of
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surements of the GBM where it intersected a grid overly- RESULTS
ing the electron micrograph [14]. None of the index cases Twenty-two families of Northern European, Southern
had light microscopic or immunofluorescent features of European, and Asian backgrounds were studied (Fig. 1
other forms of glomerulonephritis in addition to TBMD. and Table 1). The index cases included 19 females who
In each family, the eyes of the index case and often had a median age of 44 years (range of 6 to 88). Their
other family members were examined by an experienced median urinary RBC count was 173,000/mL (range
ophthalmologist for lenticonus or retinopathy consistent 74,000 to 2,180,000/mL). Only one (5%) had proteinuria
with autosomal recessive or X-linked Alport syndrome, .300 mg/L, and all had normal serum creatinine levels.
and a hearing questionnaire was administered. No abnor- One hundred fifty-nine family members were studied,
malities were detected. Furthermore, no one at the time including 130 first-degree relatives and 29 unrelated
of entry to the study knew of a family member with spouses. The presence or absence of hematuria was con-
Alport syndrome, renal failure, or inherited hearing loss. firmed in a second specimen in 87 cases, and in only
All available family members were examined. Hema- one person were the findings inconsistent (the initial
turia was used to identify affected individuals, and “af- specimen had hematuria, but the second and third speci-
fected” individuals had $30,000 glomerular RBC/mL mens were clear). Hematuria was present in 89 first-
urine. degree relatives (68%) and in 4 of the 29 (14%) unrelated
DNA from peripheral blood leukocytes or buccal spouses and was glomerular in all cases. Hematuria was
smears was extracted and amplified using standard tech- demonstrated for the first time in 46 people (29% of
niques and published conditions. Linkage to the COL4A3/ everyone tested). It was more common in females (46
COL4A4 locus was examined using at least three of the of 63, 73%) than in males (21 of 45, 47%) after the index
following, CA11, D2S351, D2S401, PAX3 microsatel- cases had been excluded (P , 0.01).
lites and a COL4A4 HaeIII intragenic restriction frag- The families of 18 index cases had hematuria in at
ment length polymorphism (RFLP), and linkage to the least two members. Ten families were aware of a positive
COL4A5 locus was examined using at least three of the family history before entering the study. Thus, 8 of the
following, 2B6, DXS456, 2B20, DXS1105, and DXS1120 12 families (67%) without a family history of TBMD
microsatellite markers. Each 10 mL reaction mix con- actually had at least two members with hematuria.
tained 50 ng genomic DNA, 100 ng primers specific for Haplotypes were informative in all families, and the
the microsatellite markers (with the 39 primer end-labeled probability of hematuria segregating with a haplotype
with g32P-ATP using T4 polynucleotide kinase; Gene- at a candidate locus in each family was calculated. For
works, Adelaide, Australia), 1 mmol/L dNTP (Phar- example, in Family MS (Fig. 1B), the putative hematuria
macia), 1 mL of 10 3 reaction buffer, 2.5 mmol/L MgCl2, haplotype at the COL4A3/COL4A4 locus was identified
and 0.5 m Taq polymerase (Geneworks). from the mother and daughter as 1211, and the likelihood
After amplification, 2 mL of formamide stop solution of the elder son who is affected having this haplotype
[95% formamide, 20 mmol/L ethylenediaminetetraacetic by chance was one half, and of the younger unaffected
acid (EDTA)] were added to each reaction tube, which son not having this haplotype was also one half. Thus,
was then incubated at 958C for 30 minutes and chilled. the probability of hematuria in this family segregating
Six microliters from each reaction mix were loaded into with the 1211 haplotype was 0.25.
individual wells and electrophoresed in a 7% denaturing In 12 families, hematuria segregated with one of the
polyacrylamide gel at 508C for two to four hours. Alleles candidate gene loci but not with the other (Table 1).
were determined by exposing the gel to x-ray film (Bio- Seven of these families were large enough that the results
max; Kodak, Rochester, NY, USA) for one to three were significant. Hematuria segregated with the COL4A3/
hours and assigned numbers according to designated COL4A4 locus in five (all P , 0.05) and was consistent
band size. Genotypes for the COL4A4 RFLPs were de- with segregation only at this locus in a further three
termined after amplification, restriction with HaeIII families. Hematuria segregated with the COL4A5 locus
(Boehringer Mannheim, Mannheim, Germany) at 378C in two families (P , 0.05) and was consistent with segre-
gation only at this locus in a further two families.for four hours, and electrophoresis in a 1% agarose gel.
Haplotypes were then constructed at the COL4A3/ In the 10 remaining families (45%), hematuria did not
segregate with either gene locus even though some ofCOL4A4 and COL4A5 loci for affected and unaffected
family members. Families were too small for formal link- these families were small, and four had only one person
with hematuria. In order to identify further families inage studies, but the probabilities of hematuria segregat-
ing with haplotypes within individual families were calcu- which incomplete penetrance of hematuria prevented
segregation with a candidate locus, haplotypes of onlylated using simple statistics.
This project had the approval of the Human Research the family members with hematuria were examined.
However, this demonstrated no further families in whichEthics Committee of the Austin and Repatriation Medi-
cal Center, and all subjects provided signed informed hematuria segregated with or was consistent with segre-
gation at either locus.consent.
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Fig. 1. (A) Families showing segregation of hematuria with haplotypes at COL4A3/COL4A4 (JW, RC, CC, TW, and NE) and COL4A5 (JR and
SS) locus (all P , 0.05). In all of these families, hematuria segregated with only one of the two candidate gene loci. Families JR and SS show
segregation of hematuria with haplotypes at COL4A5 (P , 0.05). (B) Families showing segregation of hematuria with haplotypes at COL4A3/
COL4A4 (AC, JK, and MS) and COL4A5 (AV, SL) locus (all P 5 NS). In all of these families, hematuria segregated with only one of the two
candidate gene loci. A new mutation was assumed in family SL in the index case who was the mother of the two girls. Hematuria did not segregate
with haplotypes at either locus in the remaining 10 families. The asterisk indicates recombination.
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Fig. 1. (Continued)
Of the four families in which hematuria segregated in which hematuria segregated with the COL4A3/COL4A4
with or was consistent with segregation at the COL4A5 locus had a serum creatinine of 0.28 mmol/L, and a renal
locus, the absence of males with renal failure, hearing biopsy showed TBMD and strong mesangial IgA immu-
loss, and eye abnormalities was verified in two families nofluorescence. Three of the 13 glomeruli were partly or
(SL and AV). However, these families were small and completely sclerosed, and there was moderate interstitial
did not contain any adult males, and the disease may fibrosis with areas of prominent tubular atrophy and mini-
have been due to recent mutations. In the other two mal vascular changes. His serum creatinine four years
families, the diagnosis of X-linked Alport syndrome was previously had been 0.24 mmol/L.
suspected during the course of the study in individuals Hematuria was confirmed in the four unrelated spouses.
who were not initially tested. In one family, the index This had been recognized previously in two who had
case’s six-year-old son was found to be deaf, and a subse-
hypertension and “glomerulonephritis.” None had had
quent renal biopsy demonstrated GBM thinning and
a renal biopsy; however, both parents of the third testedmarked lamellation. In the other family, a 55-year-old
negative for hematuria, and the fourth had no parentsgreat uncle was admitted to the hospital with an acute
or sibs alive who could be tested. Three of these individu-myocardial infarct and died the next day. He did not have
als had married into families in which hematuria segre-diabetes. His urine was positive for blood on dipstick and
gated with COL4A3/COL4A4. None of the four off-his serum creatinine was 0.55 mmol/L, but he was not
spring who had inherited the hematuria haplotype fromdeaf and had no known eye abnormalities. His mother
the other parent had renal failure or the hearing loss orand three sisters had hematuria, but neither his blood
eye manifestations typical of autosomal recessive Alportnor tissue was kept for DNA studies. He had no children.
An affected individual aged 28 years in a family (JW) syndrome.
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Table 1. Characteristics of proband, family members and results of linkage studies
Urinary RBC N first degree
Proband (103/mL) N family N first degree relatives with COL4A3/
(gender, age) in proband members tested relatives tested hematuria COL4A5 COL4A4 P
JR (F, 6) 1,600 11 8 (1M, 7F) 8 (1M, 7F) Yes No 0.016
JW (F, 36) 105 24 19 (10M, 9F) 11 (3M, 8F) No Yes ,0.0001
TW (M, 56) 120 13 11 (5M, 6F) 9 (3M, 6F) No Yes 0.00045
RC (F, 38) 240 7 7 (3M, 4F) 5 (2M, 3F) No Yes 0.008
CC (F, 9) 1,200 8 7 (2M, 5F) 5 (2M, 3F) No Yes 0.031
NE (F, 7) 340 8 7 (1M, 6F) 7 (1M, 6F) No Yes 0.016
SS (F, 38) 100 7 6 (2M, 4F) 3 (1M, 2F) Yes No 0.031
SL (F, 35) 950 7 3 (3F) 3 (3F) Yes No 0.50
AV (F, 10) 155 4 3 (1M, 2F) 3 (1M, 2F) Yes No 0.50
AC (M, 25) 410 6 5 (4M, 1F) 4 (3M, 1F) No Yes 0.125
JK (F, 57) 74 5 4 (4F) 4 (4F) No Yes 0.25
MS (F, 68) 240 4 4 (2M, 2F) 3 (1M, 2F) No Yes 0.25
MC (F, 49) 2,180 7 6 (3M, 3F) 4 (2M, 2F) No No NS
NM (F, 52) 180 7 6 (3M, 3F) 2 (1M, 1F) No No NS
RB (F, 32) 130 6 5 (2M, 3F) 2 (2F) No No NS
MB (F, 64) 260 7 6 (3M, 3F) 1 (1F) No No NS
HC (F, 55) 110 5 4 (1M, 3F) 3 (3F) No No NS
MK (M, 58) 435 5 4 (2M, 2F) 3 (2M, 1F) No No NS
BS (F, 68) 90 5 4 (1M, 3F) 4 (1M, 3F) No No NS
JO (F, 59) 165 5 4 (4F) 3 (3F) No No NS
MW (F, 39) 730 4 4 (1M, 3F) 1 (1F) No No NS
IC (F, 60) 100 4 3 (1M, 2F) 1 (1F) No No NS
Total 3M, 19F 74–2,180 159 130 (48M, 82F) 89 (24M, 65F)
Red blood cell (RBC) counts were demonstrated by phase contrast microscopy. Number (N) family members tested include unrelated spouses. Abbreviations
are: M, male; F, female. Number (N) first degree relatives tested may have included a selection bias, since affected members were more likely to offer to be tested.
COL4A5 and COL4A3/COL4A4 refer to whether haplotypes at these loci segregated with hematuria in families of probands. Hematuria segregated with one of
these loci in 7 families, was consistent with segregation at one of these loci in a further 5, and did not segregate at either locus in 10 families. In no family did
hematuria segregate with both loci simultaneously.
DISCUSSION is usually normal. The phase-contrast microscopic dem-
onstration of hematuria represents the “gold standard”This study demonstrated that hematuria in families
and is highly sensitive, specific, and reproducible in ourwith TBMD commonly segregates with the COL4A3/
laboratory. All hematuria demonstrated in this study inCOL4A4 locus and thus results from mutations in the
both family members and unrelated spouses containedsame genes as autosomal recessive Alport syndrome.
at least three populations of RBC and was thus dysmor-Furthermore, TBMD may sometimes be confused with
phic or “glomerular” in origin.the carrier state for X-linked Alport syndrome. How-
In this study, index cases were predominantly female,ever, nearly half the families in this study had hematuria
and female family members had hematuria more oftenthat did not segregate with the loci for either autosomal
than males. This may be partly because of a selectionrecessive or X-linked Alport disease.
bias or because TBMD affects or is recognized more
All index cases had thinning of the GBM on renal bi-
often in females than in males. At least one other clinical
opsy. At the start of the study, none had any clinical fea- study has also found TBMD more often in females [16].
tures or knew of any family members of any age with clin- The female GBM is normally thinner than in males [17],
ical features that suggested X-linked Alport syndrome, and a genetic mutation that causes further attenuation
and none had extensive lamellation of the GBM that may increase the likelihood of hematuria. On the other
might also have been consistent with this diagnosis. The hand, in some of our families, hematuria segregated with
four index cases subsequently shown to have X-linked the locus for X-linked disease, but few males were avail-
disease were all female, included one child, and had able for testing. In such families, the initial recognition
predominantly GBM thinning. It should be emphasized of a male with renal impairment would have suggested
that there are no ultrastructural criteria that will distin- the diagnosis of X-linked Alport syndrome and pre-
guish between carriers of X-linked and autosomal reces- cluded this family from examination in our study.
sive Alport syndrome. Hematuria was inherited in two thirds of our families
Glomerular hematuria was used to identify affected with TBMD in which a family history had not been
individuals within families, because it is the most com- recognized previously. Other causes of inherited hema-
mon feature of TBMD and persists throughout life [15]. turia are rare, and thus, even when there is no renal
biopsy, the diagnosis of TBMD can usually be inferredIn contrast, proteinuria is uncommon and renal function
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if the urine of the patient’s parents, sibs, or children Alport syndrome. We were unable to demonstrate that
any of the four offspring who had inherited the hematu-contains blood of glomerular origin [2]. Families with
only one affected member may occur because of reduced ria haplotype from one parent and had another parent
with hematuria also had renal failure, deafness, or thepenetrance of hematuria or de novo mutations or be-
cause families are small. eye abnormalities typical of autosomal recessive disease.
However, none of the unrelated spouses with hematuriaEfforts were made to recruit as many family members
as possible, but members of families with several affected had had a renal biopsy-confirmed diagnosis of TBMD.
In two of the four families in which hematuria segre-individuals were more likely to cooperate. The families
were too small for formal linkage studies, and the signifi- gated with the locus for X-linked Alport syndrome, males
with a hearing loss or hematuria came to our attentioncance of the results depended both on the strict segrega-
tion of hematuria with a haplotype at the candidate gene after the families had been studied. However, there were
no males with renal failure or hearing loss in the otherlocus and also with the number of family members exam-
ined. This study represents an unselected unbiased series two families with probable X-linked disease. Thus, even
a careful family history in a female carrier of X-linkedof consecutive families and patients with TBMD associ-
ated with our medical center rather than a study of only Alport syndrome may not indicate this form of inheri-
tance, especially where there are few males in the family,families large enough to produce significant results. It
reflects the type of patients who present with hematuria the only males are children, where the proband has a de
novo mutation, or where the clinical manifestations offor nephrological consultation. Although some families
had fewer than seven first-degree relatives (usually the Alport syndrome develop in later life.
Families in which hematuria did not segregate with acritical number to demonstrate significance), their small
size still allowed us to exclude both candidate gene loci haplotype at the candidate gene loci for TBMD may have
occurred because of reduced penetrance of hematuriain 10 cases. Four of these families had only one affected
individual, suggesting low penetrance of hematuria and [8, 15]. Hematuria probably occurs in most carriers of
X-linked Alport syndrome, but in only approximatelythat testing further members might not increase the sig-
nificance of the results. 80% of carriers of autosomal recessive disease [8]. In or-
der to overcome the effect of incomplete penetrance ofIn 12 families, hematuria segregated with haplotypes
at either the COL4A3/COL4A4 or COL4A5 locus, but not hematuria, pedigrees were re-examined taking into ac-
count only individuals with hematuria, but no furtherat both loci simultaneously. These results were significant,
however, in only seven families, with hematuria segregating families in which hematuria segregated with haplotypes
at the candidate gene loci were identified. However, ourwith the COL4A3/COL4A4 locus in five families and
with the COL4A5 locus in two. Hematuria was consis- ability to demonstrate segregation of hematuria with hap-
lotypes at the COL4A3/COL4A4 locus at all suggeststent with segregation at the COL4A3/COL4A4 locus in
a further three families and at the COL4A5 locus in the that hematuria is fully penetrant in at least some families,
and possibly depends on the nature of the underlyingremaining two families. While the results in these five
families were not significant, the lack of segregation at genetic mutations.
Another explanation for the lack of segregation of he-the other candidate locus increases the likelihood of
these observations not occurring by chance alone. Thus, maturia with haplotypes at candidate gene loci is the
presence of de novo mutations. These occur in approxi-TBMD is more often due to mutations in the COL4A3
and COL4A4 genes than in the COL4A5 gene. mately 15% of individuals with X-linked Alport syn-
drome [19], but their frequency in the COL4A3 andIt is uncertain how often individuals from families in
which hematuria segregates with the COL4A3/COL4A4 COL4A4 genes is not known.
A novel gene locus for TBMD could also account forlocus are actually carriers for autosomal recessive Alport
syndrome. If most cases of autosomal recessive Alport our inability to demonstrate segregation of hematuria with
the candidate gene loci in all families. If TBMD representssyndrome resulted from the mating of two unrelated
individuals with TBMD, then the prevalence of “com- a carrier state for autosomal recessive Alport syndrome,
and autosomal recessive and dominant conditions often af-pound heterozygotes” with autosomal recessive Alport
syndrome should be approximately 1/4 3 1/100 3 1/100 fect the same gene, then the new locus for autosomal domi-
nant disease [20] may also represent a locus for TBMD.(for the minimal prevalence of TBMD), which it approxi-
mates [18]. TBMD and Alport syndrome would then be Finally, in some families in which hematuria did not
segregate with the candidate gene loci, this might haveanalogous to b thalassemia trait, which causes only mild
anemia, and thalassemia major, which results in severe occurred because of coincidental hematuria from other
causes in family members who did not have the “hematu-disease, respectively. On the other hand, individuals with
TBMD might just have autosomal dominantly inherited ria haplotype.”
Most patients with TBMD have normal renal function,hematuria, and “compound heterozygotes” might infre-
quently have the clinical features of autosomal recessive but occasionally, individuals with an elevated creatinine
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Thin basement membrane nephropathy in adults with persistentare described. In our study, one such individual was dem-
hematuria. N Engl J Med 20:14–18, 1989
onstrated to have IgA glomerulonephritis in addition to 6. Netzer K-O, Seibold S, Weber M: Thin basement membrane: Do
we have a window for understanding the molecular pathogenesis?TBMD on his renal biopsy. Many forms of glomerulone-
Nephrol Dial Transplant 14:1060–1061, 1999phritis, especially IgA nephropathy, are more common in 7. Lemmink HH, Nillesen WN, Mochizuki T, et al: Benign familial
patients with TBMD [21] and are associated with a worse hematuria due to mutation of the type IV collagen a4 gene. J Clin
Invest 98:1114–1118, 1996outcome than occurs with TBMD alone [22].
8. Boye E, Mollet G, Forestier L, et al: Determination of the geno-Thus, hematuria in individuals with TBMD is more mic structure of the COL4A4 gene and of novel mutations causing
autosomal recessive Alport syndrome. Am J Hum Genet 63:1329–likely to segregate with the locus for autosomal recessive
1340, 1998than for X-linked Alport syndrome. When individuals
9. Rumpelt HJ, Langer KH, Scharer K, et al: Split and extremely
are heterozygous for mutations in the autosomal reces- thin glomerular basement membranes in hereditary nephropathy
(Alport’s syndrome). Virchows Arch A 364:225–233, 1974sive Alport locus, members of subsequent generations
10. Barker DF, Hostikka SL, Zhou J, et al: Identification of mutationswill have hematuria, but serious kidney disease is unlikely, in the COL4A5 collagen gene in Alport syndrome. Science 248:
whereas some family members of carriers of X-linked 1224–1227, 1990
11. Mochizuki T, Lemmink HH, Mariyama M, et al: Identification ofdisease are likely to develop renal failure. TBMD did
mutations in the a3(IV) and a4(IV) collagen genes in autosomal
not segregate with the locus for autosomal recessive or recessive Alport syndrome. Nat Genet 8:77–82, 1994
12. Fairley KF, Birch DF: A simple method for identifying glomerularX-linked Alport syndrome in nearly half of all of the
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